Search results
Showing 4471 to 4485 of 8212 results
Recommendation ID NG125/5 Question Which patient groups, contamination groups and which layers gain the most benefit from the use of triclosan-coated
Recommendation ID NG181/8 Question What is the impact of coexisting physical health conditions on the mortality of people with complex
Recommendation ID NG42/2 Question Cognitive assessment:- What is the impact of assessing for cognitive and behaviour change in people with
Recommendation ID NG155/12 Question What is the clinical and cost effectiveness of fitting amplification devices(s) in people with tinnitus
Recommendation ID NG155/2 Question What is the clinical and cost effectiveness of a combination management strategy consisting of sound
Recommendation ID NG155/3 Question What is the optimal method for assessing tinnitus in general practice (including consultation questions
Recommendation ID NG155/2 Question What is the clinical and cost effectiveness of a combination management strategy consisting of sound
Recommendation ID NG155/1 Question What is the clinical and cost effectiveness of cognitive behavioural therapy (CBT) for adults with tinnitus
Recommendation ID NG155/10 Question What is the clinical and cost effectiveness of amplification devices for people who are d/Deaf or who
Recommendation ID NG155/11 Question What is the clinical and cost effectiveness of psychological therapies for people who are d/Deaf or
Recommendation ID CG124/01 Question Imaging options in occult hip fracture: In people with a continuing suspicion of a hip fracture but
Recommendation ID CG187/02 Question Thiazide: In people with acute heart failure and persistent congestion, does the addition of a thiazide
Recommendation ID CG187/01 Question Dopamine: In people with acute heart failure, congestion and worsening renal function, does the addition
Recommendation ID NG106/1 Question Diuretic therapy for managing fluid overload in people with advanced heart failure in the community:-
Recommendation ID NG115/11 Question Mucolytic therapy:- In people with COPD, does mucolytic drug therapy prevent exacerbations in comparison